NanoViricides Inc. (NNVC)

[changes_iv]

Excellent post nanopatent. The plan, according to Dr. E. Seymour - CEO of NanoViricides, Inc., in a nutshell:

Proof of concept

First in humans

Validation of the rapid development program

Moves us from a pre-clinical to a clinical biopharma

World-wide recognition

NanoViricides, Inc. has rescued over 6,000 animals, infected with fatal doses of different viruses, from the jaws of death. We aim to perform the same kind of rescue on Ebola virus infected primates, at the USAMRIID, soon.